FNCH
Finch Therapeutics Group, Inc. Common Stock
FNCH
FNCH
Delisted
FNCH was delisted on the 24th of May, 2024.
46 hedge funds and large institutions have $28M invested in Finch Therapeutics Group, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 11 increasing their positions, 12 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
47% less capital invested
Capital invested by funds: $53.1M → $28M (-$25.1M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $3K
Holders
46
Holding in Top 10
2
Calls
–
Puts
$3K
Top Buyers
| 1 | +$639K | |
| 2 | +$613K | |
| 3 | +$259K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$150K |
| 5 |
Goldman Sachs
New York
|
+$98K |
Top Sellers
| 1 | -$3.36M | |
| 2 | -$958K | |
| 3 | -$242K | |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$189K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$161K |